NO20040059L - Benzo[G]kinolinderivater for behandling av glaukom og myopi - Google Patents

Benzo[G]kinolinderivater for behandling av glaukom og myopi

Info

Publication number: NO20040059L
Authority: NO; Norway
Prior art keywords: myopia; glaucoma; benzo; treatment; quinoline derivatives
Prior art date: 2001-07-09

Application number

NO20040059A

Other languages

English (en)

Other versions

NO327549B1 (no

Inventor

Rudolf Markstein

Peter Gull

Esteban Villar Pombo

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-09

Filing date

2004-01-07

Publication date

2004-01-07

2004-01-07 Application filed by Novartis Ag filed Critical Novartis Ag

2004-01-07 Publication of NO20040059L publication Critical patent/NO20040059L/no

2009-08-10 Publication of NO327549B1 publication Critical patent/NO327549B1/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Ophthalmology & Optometry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

NO20040059A 2001-07-09 2004-01-07 Benzo[G]kinolinderivater for behandling av glaukom og myopi NO327549B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01116553		2001-07-09
PCT/EP2002/007594 WO2003006458A1 (en)	2001-07-09	2002-07-08	Benzo [g] quinoline derivatives for treating glaucoma and myopia

Publications (2)

Publication Number	Publication Date
NO20040059L true NO20040059L (no)	2004-01-07
NO327549B1 NO327549B1 (no)	2009-08-10

Family

ID=8177978

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20040059A NO327549B1 (no)	2001-07-09	2004-01-07	Benzo[G]kinolinderivater for behandling av glaukom og myopi

Country Status (26)

Country	Link
US (1)	US7105528B2 (no)
EP (1)	EP1419149B1 (no)
JP (2)	JP5006505B2 (no)
KR (2)	KR101069948B1 (no)
CN (1)	CN1293071C (no)
AR (1)	AR036131A1 (no)
AT (1)	ATE443060T1 (no)
AU (1)	AU2002328856B2 (no)
BR (1)	BR0210894A (no)
CA (1)	CA2452920C (no)
DE (1)	DE60233740D1 (no)
EC (1)	ECSP024377A (no)
ES (1)	ES2330732T3 (no)
HK (1)	HK1066211A1 (no)
HU (1)	HUP0400833A3 (no)
IL (2)	IL159255A0 (no)
MX (1)	MXPA03012039A (no)
MY (1)	MY130656A (no)
NO (1)	NO327549B1 (no)
NZ (1)	NZ530314A (no)
PE (1)	PE20030240A1 (no)
PL (1)	PL208284B1 (no)
PT (1)	PT1419149E (no)
RU (1)	RU2300532C2 (no)
WO (1)	WO2003006458A1 (no)
ZA (1)	ZA200309642B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EG24415A (en) *	2002-03-07	2009-05-25	Novartis Ag	Quinoline derivatives
BRPI0414149A (pt) *	2003-09-05	2006-10-31	Novartis Ag	composições compreendendo derivados de benzo(g)-quinolina e derivados de prostaglandina
MA50800A (fr)	2017-11-24	2020-09-30	H Lundbeck As	Nouveaux promédicaments de catécholamine destinés à être utilisés dans le traitement de la maladie de parkinson
US11104697B2 (en)	2019-05-20	2021-08-31	H. Lundbeck A/S	Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11111263B2 (en)	2019-05-20	2021-09-07	H. Lundbeck A/S	Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11130775B2 (en)	2019-05-20	2021-09-28	H. Lundbeck A/S	Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11168056B2 (en)	2019-05-20	2021-11-09	H. Lundbeck A/S	Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0512952A1 (de) *	1991-05-02	1992-11-11	Sandoz Ltd.	Octahydrobenzo(g)chinolin
EP0659430A1 (en) *	1993-12-21	1995-06-28	Sandoz Ltd.	Use of benzo[g]quinolines in the treatment of glaucoma and for the prevention of progressive atrophy of the optic nerve
WO1998001444A1 (en) *	1996-07-08	1998-01-15	Novartis Ag	BENZO[g]QUINOLINE DERIVATIVES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5262422A (en)	1991-05-02	1993-11-16	Sandoz Ltd.	Octahydrobenzo[g]quinoline
TW357143B (en) *	1995-07-07	1999-05-01	Novartis Ag	Benzo[g]quinoline derivatives

2002
- 2002-07-03 PE PE2002000598A patent/PE20030240A1/es not_active Application Discontinuation
- 2002-07-05 AR ARP020102532A patent/AR036131A1/es active IP Right Grant
- 2002-07-08 IL IL15925502A patent/IL159255A0/xx unknown
- 2002-07-08 ES ES02764648T patent/ES2330732T3/es not_active Expired - Lifetime
- 2002-07-08 KR KR1020047000232A patent/KR101069948B1/ko not_active IP Right Cessation
- 2002-07-08 PL PL365254A patent/PL208284B1/pl not_active IP Right Cessation
- 2002-07-08 PT PT02764648T patent/PT1419149E/pt unknown
- 2002-07-08 MX MXPA03012039A patent/MXPA03012039A/es active IP Right Grant
- 2002-07-08 RU RU2004102398/04A patent/RU2300532C2/ru not_active IP Right Cessation
- 2002-07-08 NZ NZ530314A patent/NZ530314A/en not_active IP Right Cessation
- 2002-07-08 WO PCT/EP2002/007594 patent/WO2003006458A1/en active Application Filing
- 2002-07-08 KR KR1020097025779A patent/KR20100007983A/ko not_active Application Discontinuation
- 2002-07-08 CA CA2452920A patent/CA2452920C/en not_active Expired - Fee Related
- 2002-07-08 HU HU0400833A patent/HUP0400833A3/hu unknown
- 2002-07-08 BR BR0210894-1A patent/BR0210894A/pt not_active Application Discontinuation
- 2002-07-08 DE DE60233740T patent/DE60233740D1/de not_active Expired - Lifetime
- 2002-07-08 EP EP02764648A patent/EP1419149B1/en not_active Expired - Lifetime
- 2002-07-08 US US10/483,310 patent/US7105528B2/en not_active Expired - Fee Related
- 2002-07-08 JP JP2003512230A patent/JP5006505B2/ja not_active Expired - Fee Related
- 2002-07-08 AU AU2002328856A patent/AU2002328856B2/en not_active Ceased
- 2002-07-08 AT AT02764648T patent/ATE443060T1/de active
- 2002-07-08 CN CNB028138619A patent/CN1293071C/zh not_active Expired - Fee Related
- 2002-07-08 MY MYPI20022579A patent/MY130656A/en unknown
- 2002-12-11 EC EC2002004377A patent/ECSP024377A/es unknown
2003
- 2003-12-08 IL IL159255A patent/IL159255A/en not_active IP Right Cessation
- 2003-12-11 ZA ZA200309642A patent/ZA200309642B/xx unknown
2004
- 2004-01-07 NO NO20040059A patent/NO327549B1/no not_active IP Right Cessation
- 2004-11-15 HK HK04109018.5A patent/HK1066211A1/xx not_active IP Right Cessation
2009
- 2009-10-30 JP JP2009250333A patent/JP2010024243A/ja not_active Withdrawn

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0512952A1 (de) *	1991-05-02	1992-11-11	Sandoz Ltd.	Octahydrobenzo(g)chinolin
EP0659430A1 (en) *	1993-12-21	1995-06-28	Sandoz Ltd.	Use of benzo[g]quinolines in the treatment of glaucoma and for the prevention of progressive atrophy of the optic nerve
WO1998001444A1 (en) *	1996-07-08	1998-01-15	Novartis Ag	BENZO[g]QUINOLINE DERIVATIVES

Also Published As

Publication number	Publication date
KR20100007983A (ko)	2010-01-22
NO327549B1 (no)	2009-08-10
MY130656A (en)	2007-07-31
RU2300532C2 (ru)	2007-06-10
PL365254A1 (en)	2004-12-27
US20040171628A1 (en)	2004-09-02
AU2002328856B2 (en)	2005-08-04
BR0210894A (pt)	2004-06-22
PT1419149E (pt)	2009-11-25
ATE443060T1 (de)	2009-10-15
ECSP024377A (es)	2004-08-27
ZA200309642B (en)	2004-10-04
US7105528B2 (en)	2006-09-12
DE60233740D1 (de)	2009-10-29
IL159255A0 (en)	2004-06-01
ES2330732T3 (es)	2009-12-15
EP1419149A1 (en)	2004-05-19
CA2452920A1 (en)	2003-01-23
CN1525969A (zh)	2004-09-01
HUP0400833A2 (hu)	2004-07-28
NZ530314A (en)	2005-08-26
HK1066211A1 (en)	2005-03-18
WO2003006458A1 (en)	2003-01-23
JP5006505B2 (ja)	2012-08-22
HUP0400833A3 (en)	2010-03-29
PL208284B1 (pl)	2011-04-29
JP2010024243A (ja)	2010-02-04
CA2452920C (en)	2010-03-30
AR036131A1 (es)	2004-08-11
MXPA03012039A (es)	2004-03-26
RU2004102398A (ru)	2005-07-10
EP1419149B1 (en)	2009-09-16
CN1293071C (zh)	2007-01-03
JP2004538278A (ja)	2004-12-24
IL159255A (en)	2010-05-17
PE20030240A1 (es)	2003-04-16
KR101069948B1 (ko)	2011-10-04
KR20040013126A (ko)	2004-02-11

Legal Events

Date	Code	Title	Description
2015-02-23	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO20013380D0 (no)	2001-07-06	2-aminobenzoksazinonderivater for behandling av fedme
IS2907B (is)	2014-11-15	Bensó[d]asepínafleiður til að meðhöndla taugakvilla
NO20031442D0 (no)	2003-03-28	Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
DE60124302D1 (de)	2006-12-14	Thiazolderivate zur behandlung von ppar-lierte krankheiten
NO20031626D0 (no)	2003-04-09	Pyridonderivater for behandling av atherosklerose
EP1392292A4 (en)	2004-08-11	PYRANOINDAZOLES AND THEIR USE IN GLAUCOMA TREATMENT
NO20013381D0 (no)	2001-07-06	2-oksybenzoksazinonderivater for behandling av fedme
NO20026263L (no)	2002-12-27	Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
SI1231920T1 (sl)	2007-06-30	Uporaba epinastina za zdravljenje alergijskega renitisa/konjuktivitisa
NO20033682D0 (no)	2003-08-19	Epothilone-derivater for behandling av refraktor-tumorer
NO20015969L (no)	2002-02-06	Forbedret skleral protese for behandling av presbyopi og andre öyesykdommer
NO20014314L (no)	2001-10-11	Blandinger og metoder for behandling av stafylokokkisk infeksjon
NO20033883L (no)	2003-11-05	Heterosykliske derivater for behandling av kreft og andre proliferative sykdommer
GB2402674B (en)	2005-08-03	Compositions and methods for the treatment of glaucoma or ocular hypertension
NO20014617D0 (no)	2001-09-24	1-Arensulfonyl-2-aryl-pyrrolidin- og -piperidin-derivater for behandling av CNS-sykdommer
NO20021124D0 (no)	2002-03-06	Fremgangsmåte for fremstilling av benzoksazinderivater og mellomprodukter derfor
NO20040059L (no)	2004-01-07	Benzo[G]kinolinderivater for behandling av glaukom og myopi
CY1106409T1 (el)	2011-10-12	Παραγωγα κινολινης
EP1455780A4 (en)	2005-04-06	NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA
NO20035043D0 (no)	2003-11-13	Fremgangsmåte for behandling av okular hypertensjon og glaukom
AR026062A1 (es)	2002-12-26	Tratamiento de desordenes oculares
NO20024381D0 (no)	2002-09-13	Behandling av okular hypertensjon og gluakom
NO20012612L (no)	2001-07-17	Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20031779D0 (no)	2003-04-22	Fremgangsmåte og preparat for behandling av okular hypertensjon og glaukom
EE200200670A (et)	2004-08-16	S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks